Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 11 | -$0.95 | -$0.64 | -$0.81 |
| Q2 2026 | 11 | -$0.85 | -$0.72 | -$0.76 |
| Q3 2026 | 7 | -$0.70 | -$0.66 | -$0.68 |
| Q4 2026 | 4 | -$0.69 | -$0.66 | -$0.67 |
| Q1 2027 | 4 | -$0.51 | -$0.49 | -$0.50 |
| Q2 2027 | 5 | -$0.44 | -$0.42 | -$0.43 |
| Q3 2027 | 8 | -$0.33 | -$0.31 | -$0.32 |
| Q4 2027 | 4 | -$0.28 | -$0.26 | -$0.27 |
| Q1 2028 | 5 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2028 | 7 | -$0.02 | -$0.02 | -$0.02 |
| Q3 2028 | 10 | $0.26 | $0.27 | $0.27 |
| Q4 2028 | 5 | $0.25 | $0.26 | $0.26 |
Guardant Health Inc last posted its earnings results on Thursday, February 19th, 2026. The company reported $-0.9 earnings per share for the quarter, missing analysts' consensus estimates of $-0.76677 by $0.13323. The company had revenue of 281.27 M for the quarter and had revenue of 982.02 M for the year. Guardant Health Inc has generated $-3 earnings per share over the last year ($-3.32 diluted earnings per share) and currently has a price-to-earnings ratio of -27.33. Guardant Health Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 2025 | -$0.77 | -$1.00 | -0.23 | $272.42 M | $281.27 M |
| 10/29/2025 | Q3 2025 | -$0.48 | -$0.74 | -0.26 | $235.61 M | $265.20 M |
| 07/30/2025 | Q2 2025 | -$0.52 | -$0.80 | -0.28 | $211.47 M | $232.09 M |
| 04/30/2025 | Q1 2025 | -$0.61 | -$0.77 | -0.16 | $190.10 M | $203.47 M |
| 02/20/2025 | Q4 2024 | -$0.75 | -$0.90 | -0.15 | $192.13 M | $201.81 M |
| 11/06/2024 | Q3 2024 | -$0.55 | -$0.88 | -0.33 | $170.49 M | $191.48 M |
| 08/07/2024 | Q2 2024 | -$0.57 | -$0.84 | -0.27 | $162.59 M | $177.24 M |
| 05/09/2024 | Q1 2024 | -$0.72 | -$0.94 | -0.22 | $150.09 M | $168.49 M |
| 02/22/2024 | Q4 2023 | -$0.93 | -$1.58 | -0.65 | N/A | $155.05 M |
| 11/06/2023 | Q3 2023 | -$0.93 | -$0.73 | 0.2 | N/A | $143.03 M |
| 08/03/2023 | Q2 2023 | -$1.25 | -$0.67 | 0.58 | N/A | $137.15 M |
| 05/09/2023 | Q1 2023 | -$1.26 | -$1.30 | -0.04 | N/A | $128.71 M |
| 02/23/2023 | Q4 2022 | -$1.40 | -$1.36 | 0.04 | N/A | $126.89 M |
| 11/03/2022 | Q3 2022 | -$1.27 | -$1.58 | -0.31 | N/A | $117.40 M |
| 08/04/2022 | Q2 2022 | -$1.25 | -$2.25 | -1 | N/A | $109.14 M |
| 05/05/2022 | Q1 2022 | -$1.23 | -$1.21 | 0.02 | N/A | $96.10 M |
| 02/24/2022 | Q4 2021 | N/A | -$0.89 | N/A | N/A | $108.11 M |
| 11/04/2021 | Q3 2021 | -$0.90 | -$1.06 | -0.16 | N/A | $94.78 M |
| 08/05/2021 | Q2 2021 | -$0.87 | -$0.96 | -0.09 | N/A | $92.10 M |
| 05/06/2021 | Q1 2021 | -$0.82 | -$1.09 | -0.27 | N/A | $78.67 M |
The conference call for Guardant Health Inc's latest earnings report can be listened to online.
The conference call transcript for Guardant Health Inc's latest earnings report can be read online.
Guardant Health Inc (:GH) has a recorded annual revenue of $982.02 M.
Guardant Health Inc (:GH) has a recorded net income of $-416,277,000.Guardant Health Inc has generated $-3.32 earnings per share over the last four quarters.
Guardant Health Inc (:GH) has a price-to-earnings ratio of -27.33 and price/earnings-to-growth ratio is 8.77.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED